Advertisement
Screener

THC THERAPEUTICS, INC. Proceeds from Convertible Debt

THC THERAPEUTICS, INC. Proceeds from Convertible Debt

THC THERAPEUTICS, INC. reported Proceeds from Convertible Debt of $0 for the 6-month period ending 2024-01-31, per its 10-Q filed 2024-09-05.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromConvertibleDebt · last filed 2024-09-05

  • THC THERAPEUTICS, INC. proceeds from convertible debt for the quarter ending 2020-07-31 was $163.50K, a 72.24% decline year-over-year.
  • THC THERAPEUTICS, INC. proceeds from convertible debt for the quarter ending 2019-07-31 was $588.88K.
  • THC THERAPEUTICS, INC. proceeds from convertible debt for the quarter ending 2019-04-30 was $43.00K.
  • THC THERAPEUTICS, INC. proceeds from convertible debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • THC THERAPEUTICS, INC. proceeds from convertible debt for fiscal 2022 was $25.00K.
  • THC THERAPEUTICS, INC. proceeds from convertible debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • THC THERAPEUTICS, INC. proceeds from convertible debt for fiscal 2020 was $163.50K, a 78.67% decline from fiscal 2019.
Period endProceeds from Convertible Debt 3 monthProceeds from Convertible Debt 6 monthProceeds from Convertible Debt 9 monthProceeds from Convertible Debt 12 month
2024-01-31$0.00
10-Q · filed 2024-09-05
2023-07-31$0.00
10-K · filed 2024-02-26
2023-01-31$0.00
10-Q · filed 2024-09-05
2022-07-31$25.00K
10-K · filed 2024-02-26
2021-07-31$0.00
10-K · filed 2022-03-31
2020-07-31$163.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$163.50K
10-K · filed 2022-03-31
2020-04-30$0.00
10-Q · filed 2020-06-22
2019-07-31$588.88K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04
$631.88K
derived: sum of 2 quarters · filed 2020-11-04
$766.38K
10-K · filed 2020-11-04
2019-04-30$43.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-22
$177.50K
10-Q · filed 2020-06-22
2019-01-31$134.50K
10-Q · filed 2020-03-23